Neurocrine Biosciences Presents Positive Data From BIPARK-1 and -2 Studies of Opicapone for Parkinson’s Disease
Neurocrine Biosciences announced data analysis from two phase 3 trials evaluating opicapone added to levodopa for Parkinson’s disease was presented […]